Last updated on November 2017

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to- Severe Acne Vulgaris (Study FX2017-22)


Brief description of study

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to- Severe Acne Vulgaris (Study FX2017-22)

Detailed Study Description

If you have moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam. Eligible participants may received compensation and study drugs and related care at no cost.

Clinical Study Identifier: TX15590

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Betsy Moclair

Manhattan Medical Research
New York, NY USA
  Connect »